China myocardial infarction (MI) market is estimated to grow modestly at a CAGR of around 7.6% during the forecast period. Increasing heart attacks in the country is projected to increase the myocardial infarction market in China. According to the WHO, CVD causes one-third of the total fatalities each year in China. As per the Institute for Health Metrics and Evaluation, the incidence of CVD is increasing continuously in the country. The incidence reached 13.5 million in 2017 as compared to 12.5 million in 2014. The country is expected to have a significant market share in the myocardial infarction treatment market. As per International Trade Administration, in 2018, the global medical device market is around 42% of the size of the pharmaceuticals market, however, in China, it is around 14% only, which express a significant growth potential of the sector. The medical device market is one of the fastest-growing markets in China with double-digit growth for over a decade.

Get Sample Copy of China Myocardial Infarction Market at: https://www.omrglobal.com/request-sample/china-myocardial-infarction-market

The companies which are contributing to the growth of China myocardial infarction market include AstraZeneca PLC, Bayer AG, Lifetech Scientific Corp., Abbott Laboratories Inc., GlaxoSmithKline PLC, Pfizer Inc., Koninklijke Philips N.V., Medtronic PLC, and Merck KGaA.

The market is segmented into type, device, diagnosis, treatment, and end-user. Based on type, the market is segmented into ST-elevation myocardial infarction (STEMI) heart attacks, non-ST elevation myocardial infarction (NSTEMI) heart attacks, and silent heart attacks. Based on the device, the market is segmented into a left ventricular assist device, pacemaker, implantable cardioverter defibrillator, and others (aspiration-based catheters). Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest X-Ray, Computed Tomography (CT Scan), echocardiography, and others (blood test). Based on treatment, the market is segmented into medication and surgery. Based on end-user, the market is segmented into hospitals & clinics, Ambulatory Surgical Centers (ASCs), and research institutes.

For More Information, get A full report of China Myocardial Infarction Market is available at: https://www.omrglobal.com/industry-reports/china-myocardial-infarction-market

The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market. For instnace, in July 2018, Lifetech Scientific Corp. collaborated with Medtronic, an Ireland-based medical device manufacturer. This collaboration was aimed to combine the unique technologies of the two companies to provide highly advanced pacemakers to the heart patients in China.

Market Segmentation

China Myocardial Infarction Market by Type

Non-ST-elevation myocardial infarction (NSTEMI)
ST-elevation myocardial infarction (STEMI)
Silent Heart Attacks

China Myocardial Infarction Market by Device

Left Ventricular Assist Device (LVAD)
Pacemaker
Catheters
Implantable Cardioverter-Defibrillator (ICD)
Others (Stent Graft)

China Myocardial Infarction Market by Diagnosis

Electrocardiography (ECG)
Chest X-Ray
Computed Tomography (CT Scan)
Echocardiography
Others (Blood Test)

China Myocardial Infarction Market by Treatment

Medication
Analgesics
Thrombolytic
Antiplatelet Agents
Glycoprotein IIb/IIIa Inhibitors
Others (Beta-Adrenergic Blockers)
Surgery
Angioplasty
Bypass Surgery
Heart Transplant

China Myocardial Infarction Market by End-User

Hospital & Clinics
Ambulatory Surgical Centers
Research Institutes

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/china-myocardial-infarction-market


About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/



Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 7803040404